134 related articles for article (PubMed ID: 10348660)
1. Atypical PKC zeta is activated by ceramide, resulting in coactivation of NF-kappaB/JNK kinase and cell survival.
Wang YM; Seibenhener ML; Vandenplas ML; Wooten MW
J Neurosci Res; 1999 Feb; 55(3):293-302. PubMed ID: 10348660
[TBL] [Abstract][Full Text] [Related]
2. Mapping of atypical protein kinase C within the nerve growth factor signaling cascade: relationship to differentiation and survival of PC12 cells.
Wooten MW; Seibenhener ML; Neidigh KB; Vandenplas ML
Mol Cell Biol; 2000 Jul; 20(13):4494-504. PubMed ID: 10848576
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of atypical PKC in PC12 cells enhances NGF-responsiveness and survival through an NF-kappaB dependent pathway.
Wooten MW; Seibenhener ML; Zhou G; Vandenplas ML; Tan TH
Cell Death Differ; 1999 Aug; 6(8):753-64. PubMed ID: 10467349
[TBL] [Abstract][Full Text] [Related]
4. Selective ceramide binding to protein kinase C-alpha and -delta isoenzymes in renal mesangial cells.
Huwiler A; Fabbro D; Pfeilschifter J
Biochemistry; 1998 Oct; 37(41):14556-62. PubMed ID: 9772184
[TBL] [Abstract][Full Text] [Related]
5. Potentiation of protein kinase C zeta activity by 15-deoxy-delta(12,14)-prostaglandin J(2) induces an imbalance between mitogen-activated protein kinases and NF-kappa B that promotes apoptosis in macrophages.
Castrillo A; Través PG; Martín-Sanz P; Parkinson S; Parker PJ; Boscá L
Mol Cell Biol; 2003 Feb; 23(4):1196-208. PubMed ID: 12556480
[TBL] [Abstract][Full Text] [Related]
6. 12-O-tetradecanoylphorbol-13-acetate (TPA) inhibits osteoclastogenesis by suppressing RANKL-induced NF-kappaB activation.
Wang C; Steer JH; Joyce DA; Yip KH; Zheng MH; Xu J
J Bone Miner Res; 2003 Dec; 18(12):2159-68. PubMed ID: 14672351
[TBL] [Abstract][Full Text] [Related]
7. Signaling through CD5 involves acidic sphingomyelinase, protein kinase C-zeta, mitogen-activated protein kinase kinase, and c-Jun NH2-terminal kinase.
Simarro M; Calvo J; Vilà JM; Places L; Padilla O; Alberola-Ila J; Vives J; Lozano F
J Immunol; 1999 May; 162(9):5149-55. PubMed ID: 10227986
[TBL] [Abstract][Full Text] [Related]
8. Nerve growth factor stimulates multisite tyrosine phosphorylation and activation of the atypical protein kinase C's via a src kinase pathway.
Wooten MW; Vandenplas ML; Seibenhener ML; Geetha T; Diaz-Meco MT
Mol Cell Biol; 2001 Dec; 21(24):8414-27. PubMed ID: 11713277
[TBL] [Abstract][Full Text] [Related]
9. Lead activates nuclear transcription factor-kappaB, activator protein-1, and amino-terminal c-Jun kinase in pheochromocytoma cells.
Ramesh GT; Manna SK; Aggarwal BB; Jadhav AL
Toxicol Appl Pharmacol; 1999 Mar; 155(3):280-6. PubMed ID: 10079214
[TBL] [Abstract][Full Text] [Related]
10. Pyrrolidine dithiocarbamate-induced neuronal cell death is mediated by Akt, casein kinase 2, c-Jun N-terminal kinase, and IkappaB kinase in embryonic hippocampal progenitor cells.
Min YK; Park JH; Chong SA; Kim YS; Ahn YS; Seo JT; Bae YS; Chung KC
J Neurosci Res; 2003 Mar; 71(5):689-700. PubMed ID: 12584727
[TBL] [Abstract][Full Text] [Related]
11. Protective role of Bcl-2 on beta-amyloid-induced cell death of differentiated PC12 cells: reduction of NF-kappaB and p38 MAP kinase activation.
Song YS; Park HJ; Kim SY; Lee SH; Yoo HS; Lee HS; Lee MK; Oh KW; Kang SK; Lee SE; Hong JT
Neurosci Res; 2004 May; 49(1):69-80. PubMed ID: 15099705
[TBL] [Abstract][Full Text] [Related]
12. Ceramide inhibition of NF-kappaB activation involves reverse translocation of classical protein kinase C (PKC) isoenzymes: requirement for kinase activity and carboxyl-terminal phosphorylation of PKC for the ceramide response.
Signorelli P; Luberto C; Hannun YA
FASEB J; 2001 Nov; 15(13):2401-14. PubMed ID: 11689465
[TBL] [Abstract][Full Text] [Related]
13. Increased, not decreased activation of the insulin-like growth factor (IGF) receptor signalling pathway during ceramide-induced apoptosis.
Stewart CE; Newcomb PV; Savage PB; Dickens M; Tavare J; Holly JM
Growth Horm IGF Res; 1999 Apr; 9(2):131-42. PubMed ID: 10373346
[TBL] [Abstract][Full Text] [Related]
14. Activated Ki-ras enhances sensitivity of ceramide-induced apoptosis without c-Jun NH2-terminal kinase/stress-activated protein kinase or extracellular signal-regulated kinase activation in human colon cancer cells.
Ohmori M; Shirasawa S; Furuse M; Okumura K; Sasazuki T
Cancer Res; 1997 Nov; 57(21):4714-7. PubMed ID: 9354428
[TBL] [Abstract][Full Text] [Related]
15. Extracellular-regulated kinase 1/2, Jun N-terminal kinase, and c-Jun are involved in NF-kappa B-dependent IL-6 expression in human monocytes.
Tuyt LM; Dokter WH; Birkenkamp K; Koopmans SB; Lummen C; Kruijer W; Vellenga E
J Immunol; 1999 Apr; 162(8):4893-902. PubMed ID: 10202034
[TBL] [Abstract][Full Text] [Related]
16. The role of c-Jun N-terminal kinase activation in ceramide-induced apoptosis in PC12 cells.
Hartfield PJ; Bilney AJ; Murray AW
Biochem Soc Trans; 1998 Nov; 26(4):S327. PubMed ID: 10047841
[No Abstract] [Full Text] [Related]
17. Zeta isoform of protein kinase C prevents oxidant-induced nuclear factor-kappaB activation and I-kappaBalpha degradation: a fundamental mechanism for epidermal growth factor protection of the microtubule cytoskeleton and intestinal barrier integrity.
Banan A; Fields JZ; Zhang LJ; Shaikh M; Farhadi A; Keshavarzian A
J Pharmacol Exp Ther; 2003 Oct; 307(1):53-66. PubMed ID: 12893839
[TBL] [Abstract][Full Text] [Related]
18. Tumor necrosis factor-alpha and ceramide induce cell death through different mechanisms in rat mesangial cells.
Guo YL; Kang B; Yang LJ; Williamson JR
Am J Physiol; 1999 Mar; 276(3):F390-7. PubMed ID: 10070162
[TBL] [Abstract][Full Text] [Related]
19. Regulation of extracellular-signal regulated kinase and c-Jun N-terminal kinase by G-protein-linked muscarinic acetylcholine receptors.
Wylie PG; Challiss RA; Blank JL
Biochem J; 1999 Mar; 338 ( Pt 3)(Pt 3):619-28. PubMed ID: 10051431
[TBL] [Abstract][Full Text] [Related]
20. Stimulation of Jun N-terminal kinase (JNK) by gonadotropin-releasing hormone in pituitary alpha T3-1 cell line is mediated by protein kinase C, c-Src, and CDC42.
Levi NL; Hanoch T; Benard O; Rozenblat M; Harris D; Reiss N; Naor Z; Seger R
Mol Endocrinol; 1998 Jun; 12(6):815-24. PubMed ID: 9626657
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
